Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B

Kolevzon, 2007, Prenatal and perinatal risk factors for autism: a review and integration of findings, Arch Pediatr Adolesc Med, 161, 326, 10.1001/archpedi.161.4.326

Gillberg, 1999, Autism: not an extremely rare disorder, Acta Psychiatr Scand, 99, 399, 10.1111/j.1600-0447.1999.tb00984.x

Wingate, 2014, Prevalence of autism spectrum disorder among children aged 8 years: autism and developmental disabilities monitoring network, 11 sites, United States, 2010, MMWR Surveill Summ, 63, 1

Diez-Planelles, 2016, Circulating microRNAs in Huntington’s disease: emerging mediators in metabolic impairment, Pharmacol Res, 108, 102, 10.1016/j.phrs.2016.05.005

Abu-Elneel, 2008, Heterogeneous dysregulation of microRNAs across the autism spectrum, Neurogenetics, 9, 153, 10.1007/s10048-008-0133-5

Talebizadeh, 2008, Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism, Autism Res, 1, 240, 10.1002/aur.33

Ghahramani Seno, 2011, Gene and miRNA expression profiles in autism spectrum disorders, Brain Res, 1380, 85, 10.1016/j.brainres.2010.09.046

Mundalil Vasu, 2014, Serum microRNA profiles in children with autism, Mol Autism, 5, 40, 10.1186/2040-2392-5-40

Huang, 2015, Investigation of gene regulatory networks associated with autism spectrum disorder based on MiRNA expression in China, PloS one, 10, e0129052, 10.1371/journal.pone.0129052

Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res, 18, 997, 10.1038/cr.2008.282

Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods (San Diego, Calif, 25, 402, 10.1006/meth.2001.1262

Pradervand, 2009, Impact of normalization on miRNA microarray expression profiling, Rna, 15, 493, 10.1261/rna.1295509

Scholer, 2010, Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature, Exp Hematol, 38, 1126, 10.1016/j.exphem.2010.10.004

Backx, 2011, A balanced translocation t(6;14)(q25.3;q13.2) leading to reciprocal fusion transcripts in a patient with intellectual disability and agenesis of corpus callosum, Cytogenet Genome Res, 132, 135, 10.1159/000321577

Ka, 2016, Essential Roles for ARID1B in dendritic arborization and spine morphology of developing pyramidal neurons, J Neurosci, 36, 2723, 10.1523/JNEUROSCI.2321-15.2016

Ronzoni, 2016, Interstitial 6q25 microdeletion syndrome: ARID1B is the key gene, Am J Med Genet A, 170a, 1257, 10.1002/ajmg.a.37553

Curatolo, 2014, Synapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014, Front Cell Neurosci, 8, 309, 10.3389/fncel.2014.00309

Tang, 2014, Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits, Neuron, 83, 1131, 10.1016/j.neuron.2014.07.040

Alvarez-Mora, 2016, Comprehensive molecular testing in patients with high functioning autism spectrum disorder, Mutat Res, 784–785, 46, 10.1016/j.mrfmmm.2015.12.006

D’Gama, 2015, Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms, Neuron, 88, 910, 10.1016/j.neuron.2015.11.009

Pinto, 2014, Convergence of genes and cellular pathways dysregulated in autism spectrum disorders, Am J Hum Genet, 94, 677, 10.1016/j.ajhg.2014.03.018

Anitha, 2015, microRNA and autism, Adv Exp Med Biol, 888, 71, 10.1007/978-3-319-22671-2_5